No nod for India’s Covaxin yet as WHO seeks more data

New Delhi, October 27 (KMS): The World Health Organization (WHO) once again postponed granting approval to India’s indigenous Covid-19 vaccine Covaxin, seeking more technical details to conduct a final ‘risk-benefit assessment’.

The global body — which was reviewing data on India’s Covaxin shot against Covid-19 to grant Emergency Use Listing (EUL) — has sought additional information from Hyderabad-based Bharat Biotech to conduct a final “risk-benefit assessment” for approving the vaccine for global use.

The organization expects to receive the information by the “end of this week” and plans to conduct the final assessment on November 3.